| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/04/2011 | US20110190386 Aptamer Inhibitors of Osteopontin and Methods of Use Thereof |
| 08/04/2011 | US20110190374 Methods of treating a meiotic kinesin associated disease |
| 08/04/2011 | US20110190371 Genetic suppression and replacement |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190288 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency |
| 08/04/2011 | US20110190285 Methods of treating a botulinum toxin related condition in a subject |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190221 Modulation and repletion/enhancement of the complement system for treatment of trauma |
| 08/04/2011 | US20110190213 Retro-inverso peptides derived from interleukin-3 |
| 08/04/2011 | US20110190205 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189319 Lifeforce liquid supplement |
| 08/04/2011 | US20110189313 Method of using a green coffee bean extract to promote carnitine palmitoyltransferase activity |
| 08/04/2011 | US20110189312 Compositions and Methods for Supporting Heat Shock Protein Function |
| 08/04/2011 | US20110189296 Bone substitute containing porous bio-glass and calcium sulphate |
| 08/04/2011 | US20110189270 Differential Loading Of Drug-Eluting Medical Devices |
| 08/04/2011 | US20110189262 Methods and Compositions for Reducing Systemic Toxicity of Vectors |
| 08/04/2011 | US20110189245 Smooth, High Solids Tablet Coating Composition |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189168 Antibody-induced apoptosis |
| 08/04/2011 | US20110189160 Veterinary Topical Agent |
| 08/04/2011 | US20110189153 Compositions and Methods for Treating Collagen-Mediated Diseases |
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189110 Compositions and methods for the treatment of xerostomia |
| 08/04/2011 | US20110189100 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 08/04/2011 | CA2788326A1 Compounds for use in the treatment of diseases |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351840A1 Polypeptides involved in immune response |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351832A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same |
| 08/03/2011 | EP2351777A1 Anti-muc1 antibody |
| 08/03/2011 | EP2351744A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase |
| 08/03/2011 | EP2351742A1 Indazole derivative |
| 08/03/2011 | EP2351586A1 Pharmaceutical compositions of active polypeptides for enhanced pharmacological activity through oral and parenteral administration |
| 08/03/2011 | EP2351585A1 Anti-hepatitis c virus composition |
| 08/03/2011 | EP2351571A1 Protein phosphatase inhibitor |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 08/03/2011 | EP2350001A1 Novel benzylidene-indolinone and their medical and diagnostic uses |
| 08/03/2011 | EP2349288A2 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3) |
| 08/03/2011 | EP2349257A1 Use of paf receptor for treating infections caused by flaviviridae |
| 08/03/2011 | EP2349241A1 Pharmaceutical compositions with attenuated release of phenolic opioids |
| 08/03/2011 | EP1878429B1 Trenadermal absorption preparation |
| 08/03/2011 | EP1480634B1 Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia |
| 08/03/2011 | EP1212055B1 Neurotherapeutic composition comprising a beta-lactam compound |
| 08/03/2011 | CN1997629B Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143764A Nanocrystal nano-emulsion |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139098A Lysozyme-rich novel biological synergist |
| 08/03/2011 | CN102139053A Shrimp fertile-benefiting growth promoter |
| 08/03/2011 | CN102138964A Quality control method of Tongbaole chewing tablet |
| 08/03/2011 | CN102138941A Precursor liposome of propolis flavone and preparation method thereof |
| 08/03/2011 | CN101624868B Wood floor and preparation method thereof |
| 08/03/2011 | CN101511793B Antitumor agent for undifferentiated gastric cancer |
| 08/03/2011 | CN101316590B Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 08/03/2011 | CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
| 08/02/2011 | US7989661 Human ADAM-10 inhibitors |
| 08/02/2011 | US7989503 Smooth muscle peristole inhibitor |
| 08/02/2011 | US7989492 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 08/02/2011 | US7989490 Injectable formulations of taxanes for cad treatment |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989424 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 08/02/2011 | US7989182 Nucleic acid encoding SCN1A variant |
| 08/02/2011 | US7988999 Drug with enteric coating; oral administering |
| 08/02/2011 | US7988965 Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim |
| 08/02/2011 | US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 08/02/2011 | US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 08/02/2011 | CA2489723C Novel aryl-{4-halo-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 08/02/2011 | CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 08/02/2011 | CA2475780C 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use to prepare drugs for treatment of immunological diseases |
| 08/02/2011 | CA2474043C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 08/02/2011 | CA2471577C Chemical compounds |
| 08/02/2011 | CA2470956C 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 08/02/2011 | CA2459493C New pharmaceutical compositions for inhalation |
| 08/02/2011 | CA2458025C Novel 4-aminofuropyrimidines and the use thereof |
| 08/02/2011 | CA2449298C A coated nicotine-containing chewing gum, manufacture and use thereof |
| 08/02/2011 | CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2011 | CA2442870C Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 08/02/2011 | CA2414211C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 08/02/2011 | CA2395593C Azaindoles |
| 08/02/2011 | CA2370187C Treatment of neoplasms with viruses |
| 08/02/2011 | CA2364451C Agent for treatment of arthritic disease |
| 08/02/2011 | CA2323207C Food products having enhanced cocoa polyphenol content and processes for producing same |
| 07/28/2011 | WO2011090062A1 Piperazine compound having a pgds inhibitory effect |
| 07/28/2011 | WO2011089995A1 Hydroxamic acid derivative and hdac8 inhibitor using same |
| 07/28/2011 | WO2011089951A1 Prevention/treatment agent for diabetic retinopathy and foodstuff aiming to prevent/treat diabetic retinopathy, ameliorating agent for various symptoms of diabetic retinopathy and foodstuff aiming to ameliorate various symptoms of diabetic retinopathy, and method for determining dosing period of prevention/ameliorating agent for diabetic retinopathy |
| 07/28/2011 | WO2011089509A1 A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes |
| 07/28/2011 | WO2011089168A2 Special composition for the use thereof as a drug |
| 07/28/2011 | WO2010149378A3 Diastereomeric and enantiomeric tricyclic compounds and method for producing diastereomeric and enantiomeric bicyclic and tricyclic compounds |
| 07/28/2011 | US20110184381 Repair of defects or lesions in cartilage and bone using a chondro-regulative matrix |
| 07/28/2011 | US20110184153 Modified gherlin peptides |
| 07/28/2011 | US20110184050 Methods and means for treating dna repeat instability associated genetic disorders |